170.64

2.16% 3.61

After Hours: 170.64

Charles River Laboratories International Inc (CRL)

Overview News Price History Option Chain Financials Discussions Forecast

Charles River Laboratories International Inc stock is traded at $170.64, with a volume of 687.47K. It is up +2.16% in the last 24 hours and up +11.61% over the past month. Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Previous Close:

$167.03

Open:

$170.07

24h Volume:

687.47K

Relative Volume:

0.76

Market Cap:

$8.40B

Revenue:

$4.06B

Net Income/Loss:

$413.08M

P/E Ratio:

21.30

EPS:

8.01

Net Cash Flow:

$560.48M

1W Performance:

-2.46%

1M Performance:

+11.61%

6M Performance:

+71.07%

1Y Performance:

-11.57%

1-Day Range:

$167.69

$172.21

1-Week Range:

$166.93

$176.15

52-Week Range:

$91.86

$230.02

Charles River Laboratories International Inc Stock (CRL) Company Profile

Name

Charles River Laboratories International Inc

Sector

Healthcare (1142)

Industry

Diagnostics & Research (53)

Phone

781-222-6000

Address

251 BALLARDVALE ST, WILMINGTON, MA

Employee

20,100

Twitter

@criverlabs

Next Earnings Date

2024-11-06

Latest SEC Filings

CRL's Discussions on Twitter

Compare CRL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRL Charles River Laboratories International Inc	170.64	8.22B	4.06B	413.08M	560.48M	8.01
TMO Thermo Fisher Scientific Inc	524.58	198.17B	43.21B	6.58B	6.17B	17.28
DHR Danaher Corp	205.14	144.97B	24.01B	3.41B	4.86B	4.7082
IDXX Idexx Laboratories Inc	633.32	49.29B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	138.23	38.73B	6.79B	1.22B	1.09B	4.2644
IQV Iqvia Holdings Inc	203.77	33.69B	15.70B	1.24B	2.01B	6.9036

Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-06-25	Upgrade	William Blair	Mkt Perform → Outperform
Oct-02-25	Upgrade	Barclays	Equal Weight → Overweight
Sep-09-25	Upgrade	Jefferies	Hold → Buy
Jul-09-25	Upgrade	Citigroup	Neutral → Buy
May-23-25	Upgrade	Redburn Atlantic	Neutral → Buy
May-14-25	Upgrade	TD Cowen	Hold → Buy
May-08-25	Upgrade	Evercore ISI	In-line → Outperform
Mar-21-25	Downgrade	Goldman	Buy → Neutral
Mar-04-25	Upgrade	Citigroup	Sell → Neutral
Mar-03-25	Upgrade	Redburn Atlantic	Sell → Neutral
Jan-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Jan-17-25	Downgrade	UBS	Buy → Neutral
Nov-18-24	Downgrade	CLSA	Hold → Underperform
Nov-07-24	Upgrade	CLSA	Underperform → Hold
Oct-23-24	Initiated	CLSA	Underperform
Oct-14-24	Initiated	Redburn Atlantic	Sell
Oct-07-24	Downgrade	Evercore ISI	Outperform → In-line
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral
Oct-01-24	Downgrade	Citigroup	Neutral → Sell
Aug-08-24	Downgrade	JP Morgan	Overweight → Neutral
Aug-08-24	Downgrade	Robert W. Baird	Outperform → Neutral
Jun-28-24	Downgrade	Argus	Buy → Hold
Jun-07-24	Initiated	Mizuho	Neutral
Jun-06-24	Initiated	Goldman	Buy
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Sep-13-23	Initiated	TD Cowen	Market Perform
Jul-10-23	Downgrade	Citigroup	Buy → Neutral
Feb-23-23	Upgrade	Guggenheim	Neutral → Buy
Jan-12-23	Downgrade	Jefferies	Buy → Hold
Sep-30-22	Upgrade	Jefferies	Hold → Buy
Aug-25-22	Initiated	Credit Suisse	Outperform
Aug-04-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-24-22	Initiated	Guggenheim	Neutral
Apr-25-22	Downgrade	Jefferies	Buy → Hold
Apr-07-22	Initiated	Stephens	Overweight
Feb-17-22	Reiterated	BofA Securities	Buy
Feb-17-22	Upgrade	Citigroup	Neutral → Buy
Feb-17-22	Reiterated	Deutsche Bank	Buy
Feb-17-22	Reiterated	Morgan Stanley	Overweight
Feb-17-22	Reiterated	UBS	Buy
Aug-05-21	Resumed	Credit Suisse	Neutral
Dec-16-20	Downgrade	Citigroup	Buy → Neutral
Sep-10-20	Upgrade	Jefferies	Hold → Buy
Jul-01-20	Upgrade	BofA Securities	Neutral → Buy
May-13-20	Upgrade	UBS	Neutral → Buy
Apr-21-20	Downgrade	Jefferies	Buy → Hold
Mar-27-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Mar-02-20	Initiated	Deutsche Bank	Buy
Feb-18-20	Upgrade	Wolfe Research	Peer Perform → Outperform
Jan-10-20	Upgrade	Goldman	Neutral → Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Oct-18-19	Downgrade	BofA/Merrill	Buy → Neutral
Jun-10-19	Initiated	SVB Leerink	Outperform
Apr-30-19	Resumed	Evercore ISI	Outperform
Dec-14-18	Initiated	Deutsche Bank	Buy
Oct-09-18	Initiated	UBS	Neutral
Aug-23-18	Upgrade	Raymond James	Mkt Perform → Outperform
Jul-17-18	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jun-15-18	Upgrade	KeyBanc Capital Mkts	Sector Weight → Overweight
Feb-14-18	Upgrade	SunTrust	Hold → Buy

View All

Charles River Laboratories International Inc Stock (CRL) Latest News

12:00 PM

What does recent volatility data suggest for Charles River Laboratories International Inc.Weekly Market Report & Fast Moving Stock Watchlists - newser.com

12:00 PM

11:30 AM

Will Charles River Laboratories International Inc. bounce back from current supportQuarterly Profit Review & Target Return Focused Stock Picks - newser.com

11:30 AM

10:36 AM

Tick level data insight on Charles River Laboratories International Inc. volatilityEntry Point & Real-Time Buy Signal Alerts - newser.com

10:36 AM

10:26 AM

Understanding Charles River Laboratories International Inc.’s price movement2025 Technical Patterns & Risk Managed Investment Signals - newser.com

10:26 AM

10:05 AM

TD Cowen Adjusts Price Target on Charles River Laboratories International to $205 From $179, Maintains Buy Rating - MarketScreener

10:05 AM

09:06 AM

Why hedge funds are buying Charles River Laboratories International Inc. stockJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com

09:06 AM

08:18 AM

How to integrate Charles River Laboratories International Inc. into portfolio analysis toolsQuarterly Portfolio Summary & Community Consensus Trade Signals - newser.com

08:18 AM

08:09 AM

Can you recover from losses in Charles River Laboratories International Inc.July 2025 Recap & AI Powered Market Trend Analysis - newser.com

08:09 AM

07:56 AM

Will Charles River Laboratories International Inc. (RV6) stock sustain uptrend momentumRate Cut & High Return Trade Opportunity Guides - newser.com

07:56 AM

05:14 AM

Allspring Global Investments Holdings LLC Acquires 516,521 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat

05:14 AM

04:25 AM